Induction of responsiveness of rat diaphragm to ovine growth hormone after administration of reserpine.
The diaphragm of the pituitary intact rat is insensitive to the insulin-like effects of growth hormone unless weanling animals are used, and even then these effects are not achieved reliably. We report here that an intraperitoneal injection of reserpine is able to induce consistent responsiveness to ovine growth horomone (oGH) in hemidiaphragms from 20-27 day old rats as assessed by stimulation of 3H-AIB transport and 14C-phenylalanine incorporation into protein. Maximal stimulation of 3H-AIB transport (approximately 40%) can be elicited by addition of oGH (5 micrograms/ml) to hemidiaphragms after a 2 mg/kg injection of reserpine given 5 h prior to sacrifice. The degree of stimulation does not alter significantly if the rats are sacrificed 3, 5 or 12 h after administration of reserpine, although it decreases by 24 h. Administration of reserpine 3 h before sacrifice also leads to a 50% increase in 14C-phenylalanine incorporation into protein in rat diaphragms in response to the addition of oGH (5 micrograms/ml). The induced sensitivity to oGH is not due to inhibition of GH secretion by reserpine as demonstrated by RIA of plasma GH. Addition of a monoclonal antibody to the GH receptor (MAb263) did not result in a stimulation or inhibition of 3H-AIB uptake or stimulation of protein synthesis in reserpinized rat hemidiaphragms. These results suggest that reserpine can induce tissue responsiveness in rats 20-27 d.o. independent of plasma GH levels. Our results also imply that the type 1 GH receptor of Barnard, Bundesen, Rylatt and Waters (1985) does not mediate the insulin like actions of GH on rat diaphragm.
Department of Physiology and Pharmacology, University of Queensland, St. Lucia, Australia.
L
L
Lim
M J
MJ
Waters
D000621:Aminoisobutyric Acids / Q000493:pharmacokinetics; D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D002250:Carbon Radioisotopes; D003964:Diaphragm / Q000378:metabolism* / Q000648:ultrastructure; D000939:Epitopes; D013006:Growth Hormone / Q000378:metabolism* / Q000502:physiology; D007274:Injections, Intraperitoneal; D010649:Phenylalanine / Q000378:metabolism; D051381:Rats; D011986:Receptors, Somatotropin / Q000276:immunology / Q000378:metabolism; D012110:Reserpine / Q000008:administration & dosage / Q000494:pharmacology*
D000621:Aminoisobutyric Acids; D000911:Antibodies, Monoclonal; D002250:Carbon Radioisotopes; D000939:Epitopes; D011986:Receptors, Somatotropin; C100049:2-aminoisobutyric acid; D010649:Phenylalanine; D012110:Reserpine; D013006:Growth Hormone